Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Ubicom Holdings, Inc. (3937.T)
Tokyo, JP
Ubicom Holdings, Inc., established in Tokyo, Japan in 2005, delivers comprehensive information technology (IT) solutions primarily within Japan and across Asia. The company's diverse offerings encompass application development and testing, embedded software, and quality assurance, alongside advanced services in artificial intelligence, data analytics, and various automation technologies, including Robotic Process Automation (RPA). Beyond general IT, Ubicom specializes in medical IT solutions for hospitals and clinics. These include support for receipt processing, medical safety, data analysis, cloud services, development assistance, and consulting, all designed to navigate shifts in medical systems and mitigate labor shortages. The corporation adopted its current name, Ubicom Holdings, Inc., in July 2017, having previously been known as AWS Holdings, Inc.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +1.89% | +1.29% | +2.92% | +6.35% | -2.57% | -1.16% | -0.49% | -44.21% | -65.40% | +7.58% | +7.58% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Software - Application: +13.0%-5.5% Q1'26: -1.7% (vs Q1'25)
-
EPS growth Software - Application: +28.6%+3.5% Q1'26: -23.4% (vs Q1'25)
-
FCF margin FCF growth · Software - Application: +45.3%+18.4% Q1'26: +0.0% (vs Q1'25)
-
EBIT margin Software - Application: +9.4%+21.8% ★ Q1'26: +19.9% (vs Q1'25)
-
ROIC Software - Application: +7.5%+79.0% ★ Q1'26: +65.7% (vs Q1'25)
-
Share dilution Software - Application: +0.0%+0.4% Q1'26: -0.3% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Software - Application: -1.16×0.19× ★ Q1'26: 0.20× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Mar 2018 actual |
Mar 2019 actual |
Mar 2020 actual |
Mar 2021 actual |
Mar 2022 actual |
Mar 2023 actual |
Mar 2024 actual |
Mar 2025 actual |
Mar 2026 1 Rev. Ana. 1 EPS Ana. |
Mar 2027 1 Rev. Ana. 1 EPS Ana. |
Mar 2028 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
3.21B
est: 3.57B (-10.2%)
|
3.56B
est: 3.67B (-3.2%)
|
4.04B
est: 4.07B (-0.8%)
|
4.20B
est: 4.25B (-1.2%)
|
4.73B
est: 4.75B (-0.5%)
|
5.25B
est: 5.40B (-2.8%)
|
5.94B
est: 6.45B (-7.9%)
|
6.34B
est: 6.52B (-2.7%)
|
5.92B
5.61B – 6.23B
-9.2% YoY
|
6.40B
6.40B – 6.40B
+8.1% YoY
|
7.00B
7.00B – 7.00B
+9.4% YoY
|
| EBITDA |
401.31M
est: 810.31M (-50.5%)
|
670.92M
est: 832.76M (-19.4%)
|
842.22M
est: 923.02M (-8.8%)
|
1.07B
est: 963.84M (+10.8%)
|
1.14B
est: 1.08B (+5.4%)
|
1.17B
est: 1.22B (-4.6%)
|
1.25B
est: 1.50B (-17.0%)
|
1.51B
est: 1.71B (-11.5%)
|
1.55B
1.47B – 1.63B
-9.2% YoY
|
1.68B
1.68B – 1.68B
+8.1% YoY
|
1.84B
1.84B – 1.84B
+9.4% YoY
|
| EBIT |
322.37M
est: 703.02M (-54.1%)
|
564.46M
est: 722.50M (-21.9%)
|
707.91M
est: 800.81M (-11.6%)
|
919.53M
est: 836.22M (+10.0%)
|
1.02B
est: 934.60M (+9.3%)
|
1.01B
est: 1.06B (-4.8%)
|
1.07B
est: 1.31B (-18.2%)
|
1.32B
est: 1.47B (-10.8%)
|
1.34B
1.27B – 1.41B
-9.2% YoY
|
1.45B
1.45B – 1.45B
+8.1% YoY
|
1.58B
1.58B – 1.58B
+9.4% YoY
|
| Net Income |
212.78M
est: 237.81M (-10.5%)
|
368.57M
est: 318.70M (+15.6%)
|
533.35M
est: 456.31M (+16.9%)
|
623.77M
est: 647.05M (-3.6%)
|
832.14M
est: 785.88M (+5.9%)
|
573.79M
est: 717.07M (-20.0%)
|
526.14M
est: 975.40M (-46.1%)
|
858.40M
est: 969.86M (-11.5%)
|
929.85M
920.85M – 938.86M
-4.1% YoY
|
1.00B
1.00B – 1.00B
+7.6% YoY
|
1.10B
1.10B – 1.10B
+9.9% YoY
|
| SGA |
966.88M
est: 718.04M (+34.7%)
|
991.13M
est: 737.93M (+34.3%)
|
1.01B
est: 817.91M (+23.8%)
|
903.30M
est: 854.09M (+5.8%)
|
981.89M
est: 954.57M (+2.9%)
|
1.04B
est: 1.09B (-4.2%)
|
1.18B
est: 1.30B (-9.5%)
|
1.20B
est: 1.30B (-8.1%)
|
1.18B
1.12B – 1.24B
-9.2% YoY
|
1.28B
1.28B – 1.28B
+8.1% YoY
|
1.40B
1.40B – 1.40B
+9.4% YoY
|
| EPS |
19.08
est: 19.70 (-3.1%)
|
32.57
est: 26.40 (+23.4%)
|
46.17
est: 37.80 (+22.1%)
|
53.25
est: 53.60 (-0.7%)
|
70.38
est: 65.10 (+8.1%)
|
48.68
est: 59.40 (-18.0%)
|
44.73
est: 80.80 (-44.6%)
|
71.13
est: 80.00 (-11.1%)
|
76.70
75.96 – 77.44
-4.1% YoY
|
82.50
82.50 – 82.50
+7.6% YoY
|
90.70
90.70 – 90.70
+9.9% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-18 | A | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 3/5 | 3/5 |
| 2026-05-15 | A | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 4/5 | 3/5 |
| 2026-05-14 | A | 4/5 | 5/5 | 4/5 | 5/5 | 3/5 | 3/5 | 3/5 |
| 2026-05-13 | A | 4/5 | 5/5 | 4/5 | 5/5 | 3/5 | 3/5 | 3/5 |
| 2026-05-12 | A | 4/5 | 5/5 | 4/5 | 5/5 | 3/5 | 3/5 | 3/5 |
| 2026-05-11 | A | 4/5 | 5/5 | 4/5 | 5/5 | 3/5 | 3/5 | 3/5 |
| 2026-05-08 | A+ | 5/5 | 5/5 | 4/5 | 5/5 | 3/5 | 4/5 | 4/5 |
| 2026-05-07 | A+ | 5/5 | 5/5 | 4/5 | 5/5 | 3/5 | 4/5 | 4/5 |
| 2026-05-01 | A+ | 5/5 | 5/5 | 4/5 | 5/5 | 3/5 | 4/5 | 4/5 |
| 2026-04-30 | A+ | 5/5 | 5/5 | 4/5 | 5/5 | 3/5 | 4/5 | 4/5 |
| 2026-04-28 | A+ | 5/5 | 5/5 | 4/5 | 5/5 | 3/5 | 4/5 | 4/5 |
| 2026-04-27 | A+ | 5/5 | 5/5 | 4/5 | 5/5 | 3/5 | 4/5 | 4/5 |
| 2026-04-24 | A+ | 5/5 | 5/5 | 4/5 | 5/5 | 3/5 | 4/5 | 4/5 |
| 2026-04-23 | A+ | 4/5 | 5/5 | 4/5 | 5/5 | 3/5 | 4/5 | 3/5 |
| 2026-04-22 | A+ | 4/5 | 5/5 | 4/5 | 5/5 | 3/5 | 4/5 | 3/5 |
| 2026-04-21 | A+ | 4/5 | 5/5 | 4/5 | 5/5 | 3/5 | 4/5 | 3/5 |
| 2026-04-20 | A+ | 4/5 | 5/5 | 4/5 | 5/5 | 3/5 | 4/5 | 3/5 |
| 2026-04-17 | A | 4/5 | 5/5 | 4/5 | 5/5 | 3/5 | 3/5 | 3/5 |
| 2026-04-16 | A | 4/5 | 5/5 | 4/5 | 5/5 | 3/5 | 3/5 | 3/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Amundi Japan TOPIX II UCITS ETF EUR Dist JPNU.L | 0.00% | 9.2K | 0.45% |
| 2 | Dimensional - International Small Cap ETF DFIS | 0.00% | 53.2K | 0.39% |
| 3 | iShares Core TOPIX ETF 1475.T | 0.00% | 79.0K | 0.05% |
| 4 | Dimensional - International Core Equity 2 ETF DFIC | 0.00% | 41.5K | 0.22% |
| 5 | Dimensional World ex U.S. Core Equity 2 ETF DFAX | 0.00% | 30.4K | 0.28% |
| 6 | Dimensional - International Core Equity Market ETF DFAI | 0.00% | — | 0.18% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Akisato Kitaoka | EGM of Corporate Div. & Medical Business Div., Senior Manager of Business Planning Dept. & Director | — | male |
| Kazuhide Miyoshi | Executive Officer & Deputy Executive GM of Technology Consulting Business Division | — | — |
| Masayuki Aoki | Chairman, President & Chief Executive Officer | — | male |
| Nahoko Noguchi | Executive Officer, Chief Financial Officer, Deputy EGM of Corporate Division, GM of Administration & HR Management Dept. | — | — |
| Nanju Zen | Exec. Officer & Sr. Manager of Technology Consulting Business Div. & Transformation Strategy Dept. | — | — |
| Naoki Takahashi | Executive Officer, Head of Technology Consulting Division & Prime Solutions Division | — | — |
| Peter Uy Tan | EO, GM of AI Enterprise & Tech Consulting Bus Div and Executive PMO of AI Innovation Center | — | — |
| Shingo Chiba | EO of Medical Business Div. & New Alliance Strategy & Dy Sr. Manager Business Planning Dept. | — | — |
| Tomomi Shirai | Unit Manager of Corporate Division, IR/PR & Secretary Office | — | — |
| Yasutaka Kawakita | Executive Officer of Medical Business Division & Insurance Business Strategy | — | — |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 3937.T
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
